Knowledge base
MedicinesChecked against the official source
Risk-analysis system for pharmaceutical regulatory compliance oversight
Procedure for an electronic system assessing the risk of regulatory non-compliance in pharmaceutical activity. Annexes provide indicators for manufacturing, compounding, wholesale and retail operations.
- Act type
- Order of the Minister of Health
- No.
- 24
- Adopted
- 26 August 2026
- Ministry of Justice registration
- No. 3940, 16 September 2026
- Section
- Licensing and supervision
Official text
Risk-analysis system for pharmaceutical regulatory compliance oversight
Order of the Minister of Health · No. 24 · 26 August 2026
Related documents
- Cabinet of Ministers Resolution · No. 577 · 19 October 2026Historical versionOn introducing a system that grants medical and pharmaceutical workers the right to practise through state registrationMedicines
- Presidential Decree · No. UP-192 · 10 September 2026Checked against the official sourceOn introducing a system of state registration of medical and pharmaceutical workersMedicines
- Presidential Decree · No. UP-8 · 9 January 2024Checked against the official sourceOn reducing mandatory requirements and simplifying licensing and permit procedures for businessCosmeticsMedicines